With AI shifting the role of software engineers, Google's senior director of product says more developers will be involved in ...

Cybin® is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet ...

Discover the top 7 most in-demand college majors in the U.S. for 2025, including Computer Science, Nursing, and Business ...

Athos Therapeutics launches a new AI platform, Athos Omics AI, to provide no-code, micro-analytics for drug, food, and ...

Doctors told him that his bowel just needed time to heal. “It got to the point where I couldn’t go out, because I would ...

In recent years, significant therapeutic advances across multiple disease areas—including immuno-oncology, metabolic diseases such as type 2 diabetes and ...

Stockhead, in partnership with IR Department and Morgans, hosted the second HealthInvest 2025 event in Sydney this week.

MapLight Therapeutics is a clinical-stage biopharma focused on CNS disorders and has filed for a $100M U.S. IPO to fund its ...

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...

Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable ...

Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...